A randomized, open-label, Phase III trial of pertuzumab retreatment in HER2-positive locally advanced/metastatic breast cancer patients previously treated with pertuzumab, trastuzumab and chemotherapy: the Japan Breast Cancer Research Group-M05 PREC
| Image |  |
|---|---|
| Description | scientific article published on 01 September 2018 |
| Author/s |
author: Hiroshi Tada Hiroji Iwata Norikazu Masuda Masakazu Toi Shigehira Saji Shinji Ohno |
| Publication date | September 1, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |